The honest answer
The one everyone knows — and the base of the blend.
Short answer
BPC-157 is a peptide studied mostly in preclinical research for blood-vessel growth (angiogenesis) in slow-healing tissue like tendon and ligament. It's the base of BPC Matrix. On its own it's mostly working one part of the repair process — blood supply — which is why the blend adds three more peptides for the rest. Studied, not proven; individual results vary.
Slow-healing tissue heals slowly because it gets little blood. BPC-157 has been studied in exactly that context, which is why it anchors the blend.
On its own, 157 covers blood supply. BPC Matrix keeps it as the foundation and stacks TB-4, KPV and MGF for cell migration, inflammation and muscle — see how the blend works.
Straight answers
No. BPC-157 is one peptide; BPC Matrix is a physician-supervised blend that uses BPC-157 as its base plus TB-4, KPV and MGF.
No. It is not an FDA-approved drug and is accessed through a licensed physician.